Travere Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March:

Cowen 44th Annual Health Care Conference
Monday, March 4, 2024, at 9:10 a.m. ET

Leerink Partners Global Biopharma Conference
Monday, March 11, 2024, at 1:20 p.m. ET

Barclays 26th Annual Global Healthcare Conference
Tuesday, March 12, 2024, at 2:05 p.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit

Contact Info


Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.